Revvity (United States)
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Revvity (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
52%
Total
Publications
414
Total Open
Publications
215
Total
Citations
14K
Open Access
Percentage
52%
Total
Publications
414
Total Open
Publications
215
Total
Citations
14K
Breakdown
Publisher Open
15%
Both
26%
Other Platform Open
9%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
78
Hybrid 25%
41
No Guarantees 27%
44
Other Platform Open
Domain 62%
91
Institution 41%
60
Other Internet 21%
31
Public 10%
15
Preprint 8%
12
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 92 |
DOI | Other Internet | 30 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 24 |
Figshare | Public | 13 |
bioRxiv | Preprint | 8 |
University of Cambridge | Institution | 6 |
Europe PMC | Domain | 6 |
University of Nottingham | Institution | 4 |
Loughborough University | Institution | 4 |
Imperial College London | Institution | 4 |